2026 · 3rd Quarter (July 1 - Sep 30)

ACCENDRA HEALTH INC.

Filed by ACCENDRA HEALTH INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Termination
Posted: Sep 28, 2026
Income: Not reported
Expenses: $200,000.00
Registrant: ACCENDRA HEALTH INC.
Client: ACCENDRA HEALTH INC.
Filing UUID: b150fc01-f823-426d-aefb-f780f199435e
Termination date: Sep 30, 2026

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Literal federal measure citations: S. 4037, H.R. 2005, S. 2951, H.R. 2902, S. 1406, H.R. 8871

BUD · Budget/Appropriations

FY 2027 Appropriations.

HCR · Health Issues

Issues related to patient access to home medical equipment and related reimbursement.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.